FDA’s Drug Office Handling Disputes, Complaints Goes Dark (1)

The FDA’s office that investigates complaints and disputes between reviewers and the drug industry is currently unavailable following US Health Secretary Robert F. Kennedy Jr.’s massive layoffs across federal health agencies.

The office, known as the Center for Drug Evaluation and Research Ombuds, receives questions and investigates complaints from regulated industry, law firms, and health-care providers to informally resolve disputes between those entities and the FDA’s drug reviewers.

Bloomberg Law received an automated email Friday from CDER Ombuds that said its “services are currently unavailable at the Food and Drug Administration.”

“We recommend that you email us again in May, ...